Melanóma: vizsgálatok itt: Svédország
25 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 10.. Ask the study team whether a trial fits you.
- No phaseTaking peopleImplementation of Teledermoscopy and Artificial Intelligence
- Where
- Lund
- Életkor
- 15 év and over
- People
- 8000
- Run by
- Region Skane
See details and how to joinNCT05033678 - 2/3. fázisTaking peopleSafety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
- Where
- Gavle, Solna
- Életkor
- 18 év and over
- People
- 740 worldwide
- Run by
- Eikon Therapeutics
See details and how to joinNCT06697301 · EU 2024-512659-19-00 - 3. fázisTaking peopleStudy to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
- Where
- Goteborg
- Életkor
- 18 év to 70 év
- People
- 670 worldwide
- Run by
- Iovance Biotherapeutics, Inc.
See details and how to joinNCT05727904 · EU 2022-503140-41-00 - 1/2. fázisTaking peopleBI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
- Where
- Gothenburg, Lund, Stockholm
- Életkor
- 18 év and over
- People
- 250 worldwide
- Run by
- BioInvent International AB
See details and how to joinNCT04752826 · EU 2023-509847-29-00 - 3. fázisTaking peopleSWE-NEO: Swedish NeoAdjuvant Trial Comparing anti-PD-1 Monotherapy to Combined anti-CTLA-4/anti-PD-1 blockade in Resectable Stage III Melanoma
- Where
- Goteborg, Linkoping, Lund, Orebro, Solna, Umea
- Életkor
- 18 év and over
- People
- 128
- Run by
- Karolinska University Hospital
See details and how to join2024-519593-39-00 · EU 2024-519593-39-00 - 2. fázisTaking peopleNeoadjuvant Pembrolizumab in Patients With Stage IIb/c Melanoma
- Where
- Goteborg
- Életkor
- 18 év and over
- People
- 30
- Run by
- Vastra Gotaland Region
See details and how to joinNCT07349303 · EU 2024-519594-19-00 - 1/2. fázisNot yet taking people in SvédországMelanoma-TBK1-inhibitor enhanced Immuno Therapy with Checkpoint Inhibitors: a Phase IB/II Trial in Unresectable Stage III or Stage IV Cutaneous Melanoma
- Where
- Goteborg, Lund, Solna, Uppsala
- Életkor
- 18 év and over
- People
- 105
- Run by
- Karolinska University Hospital
See details and how to join2026-526821-16-00 · EU 2026-526821-16-00 - 1/2. fázisTaking peopleA Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
- Where
- Lund
- Életkor
- 6 hónap to 17 év
- People
- 370 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT02332668 · EU 2022-501257-36-00 - 3. fázisTaking peopleAdjuvant Tebentafusp in High Risk Ocular Melanoma
- Where
- Goteborg
- Életkor
- 18 év and over
- People
- 290 worldwide
- Run by
- European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT06246149 · EU 2023-510333-28-00 - 3. fázisTaking peopleA Phase III Randomized Controlled Multicentre Trial of Percutaneous Hepatic Perfusion in Combination with Ipilimumab and Nivolumab Compared to Ipilimumab and Nivolumab Only in Patients with Uveal Melanoma Liver Metastases – the SCANDIUM III trial.
- Where
- Goteborg, Linkoping, Lund, Solna, Umeå, Uppsala
- Életkor
- 18 év and over
- People
- 50 worldwide
- Run by
- Vaestra Goetalandsregionen
See details and how to join2023-508156-20-00 · EU 2023-508156-20-00 - 3. fázisTaking peopleAssessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma
- Where
- Eskilstuna, Falun, Gavle, Goteborg, Jonkoping, Kalmar, Karlstad, Linkoping, Lund, Orebro, Stockholm, Sundsvall, Umea, Uppsala, Vasteras, Vaxjo
- Életkor
- 18 év and over
- People
- 1792 worldwide
- Run by
- Uppsala University
See details and how to joinNCT06488482 · EU 2023-509994-22-00 - 3. fázisTaking peopleIMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
- Where
- Gothenburg, Jönköping, Lund, Stockholm, Uppsala
- Életkor
- 18 év and over
- People
- 680 worldwide
- Run by
- Immunocore Ltd
See details and how to joinNCT06112314 - 3. fázisTaking peopleEfficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients
- Where
- Goteborg
- Életkor
- 18 év and over
- People
- 186 worldwide
- Run by
- Philogen S.p.A.
See details and how to joinNCT03567889 · EU 2023-507119-36-00 - 3. fázisTaking peopleSWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III Melanoma
- Where
- Gothenburg, Lund, Stockholm
- Életkor
- 18 év and over
- People
- 128
- Run by
- Hildur Helgadottir
See details and how to joinNCT06794775 - 3. fázisTaking peopleAdjuvant Melatonin for Uveal Melanoma
- Where
- Stockholm
- Életkor
- 18 év and over
- People
- 100
- Run by
- Gustav Stalhammar
See details and how to joinNCT05502900 - No phaseTaking peoplePrecision Radiation of Immune Checkpoint Therapy Resistant Melanoma Metastases
- Where
- Stockholm
- Életkor
- 18 év and over
- People
- 27
- Run by
- Karolinska University Hospital
See details and how to joinNCT04793737 - No phaseTaking peopleWoW - Single- vs Two-staged Excisions of Thin Melanoma
- Where
- Gothenburg
- Életkor
- 18 év and over
- People
- 2486
- Run by
- Vastra Gotaland Region
See details and how to joinNCT06363591 - 1. fázisNot yet taking people in SvédországA study of safety, feasibility and immunologic response of transfering tumor infiltrating lymphocytes with or without dendritic cell vaccination in patients with metastatic melanoma
- Where
- Solna
- Életkor
- 18 év and over
- People
- 20
- Run by
- Karolinska University Hospital
See details and how to join2024-519060-40-00 · EU 2024-519060-40-00 - No phaseTaking peopleA Randomized Trial to Assess the Role of Imaging During Follow Up After Radical Surgery of High Risk Melanoma
- Where
- Borås, Eskilstuna, Falun, Gävle, Gothenburg, Helsingborg, Jönköping, Kalmar, Karlstad, Linköping, Malmö, Örebro, Skövde, Stockholm, Sundsvall, Uddevalla, Umeå, Uppsala, Västerås, Visby
- Életkor
- 18 év and over
- People
- 1300
- Run by
- Uppsala University
See details and how to joinNCT03116412 - No phaseTaking peopleMelanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
- Where
- Gothenburg, Kristianstad
- Életkor
- 18 év and over
- People
- 2998 worldwide
- Run by
- Melanoma and Skin Cancer Trials Limited
See details and how to joinNCT03860883 - 3. fázisTaking peoplePHP in Combination With IPI1/NIVO3 Compared to IPI3/NIVO1 Only in Patients With Uveal Melanoma Liver Metastases
- Where
- Gothenburg, Linköping, Lund, Stockholm, Umeå, Uppsala
- Életkor
- 18 év and over
- People
- 40
- Run by
- Vastra Gotaland Region
See details and how to joinNCT06519266 - 1/2. fázisTaking peopleIntradermal Ipilimumab and Nivolumab in High Risk Stage II Melanoma
- Where
- Goteborg
- Életkor
- 18 év and over
- People
- 96 worldwide
- Run by
- The Netherlands Cancer Institute
See details and how to joinNCT06240143 · EU 2023-505945-19-00 - 3. fázisTaking peopleAMUM trial -Adjuvant Melatonin for Uveal Melanoma: A randomized open Phase III Study
- Where
- Stockholm
- Életkor
- 18 év and over
- People
- 100
- Run by
- St Erik Eye Hospital
See details and how to join2022-500307-49-00 · EU 2022-500307-49-00 - 1/2. fázisTaking peopleEvaluating the Effect of Nivolumab for Patients With In-transit Metastases Treated With Isolated Limb Perfusion
- Where
- Goteborg
- Életkor
- 18 év and over
- People
- 74 worldwide
- Run by
- Vastra Gotaland Region
See details and how to joinNCT03685890 · EU 2023-509265-21-00 - No phaseTaking peopleBioMEL- Diagnostic and Prognostic Factors in Melanoma.
- Where
- Helsingborg, Kristianstad, Lund, Malmö
- Életkor
- 18 év and over
- People
- 2000
- Run by
- Region Skane
See details and how to joinNCT05446155